https://orcid.org/0000-0001-8225-241X
Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Maria Luisa Varela, Andrea Comba, Syed M Faisal, Anna Argento, Andrea Franson, Marcus N Barissi, Sean Sachdev, Maria G Castro & Pedro R Lowenstein. (2023) Gene Therapy for High Grade Glioma: The Clinical Experience. Expert Opinion on Biological Therapy 23:2, pages 145-161.
Read now
Read now
Boyang Yuan, Guoqing Wang, Xin Tang, Aiping Tong & Liangxue Zhou. (2022) Immunotherapy of glioblastoma: Recent advances and future prospects. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Wei Zhang, Clark C. Chen & Jianfang Ning. (2021) Combining oncolytic virus with FDA approved pharmacological agents for cancer therapy. Expert Opinion on Biological Therapy 21:2, pages 183-189.
Read now
Read now
Articles from other publishers (34)
Samuel Luca Rocha Pinheiro, Fabian Fellipe Bueno Lemos, Hanna Santos Marques, Marcel Silva Luz, Luís Guilherme de Oliveira Silva, Clara Faria Souza Mendes dos Santos, Karolaine da Costa Evangelista, Mariana Santos Calmon, Matheus Sande Loureiro & Fabrício Freire de Melo. (2023) Immunotherapy in glioblastoma treatment: Current state and future prospects. World Journal of Clinical Oncology 14:4, pages 138-159.
Crossref
Crossref
Tanvir Ahmed. (2023) Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme. MedComm – Oncology 2:1.
Crossref
Crossref
Azzam Hamad, Gaukhar M. Yusubalieva, Vladimir P. Baklaushev, Peter M. Chumakov & Anastasiya V. Lipatova. (2023) Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies. Viruses 15:2, pages 547.
Crossref
Crossref
Seyyed Mehdy Elahi, Nazila Nazemi-Moghaddam, Claire Guilbault, Mélanie Simoneau & Rénald Gilbert. (2023) Complementary Cell Lines for Protease Gene-Deleted Single-Cycle Adenovirus Vectors. Cells 12:4, pages 619.
Crossref
Crossref
Ana Cloquell, Isidro Mateo, Stefano Gambera, Martí Pumarola, Ramon Alemany, Javier García-Castro & Ana Judith Perisé-Barrios. (2022) Systemic cellular viroimmunotherapy for canine high-grade gliomas. Journal for ImmunoTherapy of Cancer 10:12, pages e005669.
Crossref
Crossref
Gelare Ghajar-Rahimi, Kyung-Don Kang, Stacie K. Totsch, Sam Gary, Abbey Rocco, Sarah Blitz, Kara Kachurak, M.R. Chambers, Rong Li, Elizabeth A. Beierle, Asim Bag, James M. Johnston, James M. Markert, Joshua D. Bernstock & Gregory K. Friedman. (2022) Clinical advances in oncolytic virotherapy for pediatric brain tumors. Pharmacology & Therapeutics 239, pages 108193.
Crossref
Crossref
Lushun Chalise, Akira Kato, Masasuke Ohno, Sachi Maeda, Akane Yamamichi, Shunichiro Kuramitsu, Satoshi Shiina, Hiromi Takahashi, Sachiko Ozone, Junya Yamaguchi, Yukinari Kato, Yumi Rockenbach, Atsushi Natsume & Tomoki Todo. (2022) Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma. Molecular Therapy - Oncolytics 26, pages 265-274.
Crossref
Crossref
Zahra Fekrirad, Amir Barzegar Behrooz, Shokoofeh Ghaemi, Arezou Khosrojerdi, Atefeh Zarepour, Ali Zarrabi, Ehsan Arefian & Saeid Ghavami. (2022) Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. Cancers 14:15, pages 3698.
Crossref
Crossref
Asraa Faris Aldoghachi, Ahmed Faris Aldoghachi, Koen Breyne, King-Hwa Ling & Pike-See Cheah. (2022) Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme. Neuroscience 491, pages 240-270.
Crossref
Crossref
Sakhawat Ali, Qin Xia, Tahir Muhammad, Liqun Liu, Xinyi Meng, David Bars-Cortina, Aamir Ali Khan, Yinghui Huang & Lei Dong. (2021) Glioblastoma Therapy: Rationale for a Mesenchymal Stem Cell-based Vehicle to Carry Recombinant Viruses. Stem Cell Reviews and Reports 18:2, pages 523-543.
Crossref
Crossref
Jing Chen, Qiang Zhang, Yuandong Zhuang, Shuang Liu, Xi Zhou & Guoliang Zhang. (2022) Molecular mechanism of GANT61 combined with doxorubicin in the treatment of gliomas based on network pharmacology. Electronic Journal of Biotechnology 55, pages 18-26.
Crossref
Crossref
Greyson Willis Grossman Biegert, Amanda Rosewell Shaw & Masataka Suzuki. (2021) Current development in adenoviral vectors for cancer immunotherapy. Molecular Therapy - Oncolytics 23, pages 571-581.
Crossref
Crossref
Seyyed Mehdy Elahi, Nazila Nazemi-Moghaddam, Christine Gadoury, Julie Lippens, Stevo Radinovic, Marie-Hélène Venne, Anne Marcil & Rénald Gilbert. (2021) A rapid Focus-Forming Assay for quantification of infectious adenoviral vectors. Journal of Virological Methods 297, pages 114267.
Crossref
Crossref
Gustavo Ignacio Vázquez Cervantes, Dinora F. González Esquivel, Saúl Gómez-Manzo, Benjamín Pineda & Verónica Pérez de la Cruz. (2021) New Immunotherapeutic Approaches for Glioblastoma. Journal of Immunology Research 2021, pages 1-19.
Crossref
Crossref
Irene Appolloni, Francesco Alessandrini, Laura Menotti, Elisa Avitabile, Daniela Marubbi, Noemi Piga, Davide Ceresa, Francesca Piaggio, Gabriella Campadelli-Fiume & Paolo Malatesta. (2021) Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma. Viruses 13:9, pages 1677.
Crossref
Crossref
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, Marat P. Valikhov & Vladimir P. Chekhonin. (2021) A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation. Scientific Reports 11:1.
Crossref
Crossref
A.B. Carpenter, A.M. Carpenter, R. Aiken & S. Hanft. (2021) Oncolytic virus in gliomas: a review of human clinical investigations. Annals of Oncology 32:8, pages 968-982.
Crossref
Crossref
Benjamin B. Kasten, Hailey A. Houson, Jennifer M. Coleman, Jianmei W. Leavenworth, James M. Markert, Anna M. Wu, Felix Salazar, Richard Tavaré, Adriana V. F. Massicano, G. Yancey Gillespie, Suzanne E. Lapi, Jason M. Warram & Anna G. Sorace. (2021) Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model. Scientific Reports 11:1.
Crossref
Crossref
Miika Martikainen, Mohanraj Ramachandran, Roberta Lugano, Jing Ma, Minttu-Maria Martikainen, Anna Dimberg, Di Yu, Andres Merits & Magnus Essand. (2021) IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma. Molecular Therapy - Oncolytics 21, pages 37-46.
Crossref
Crossref
Estela Núñez-Manchón, Martí Farrera-Sal, Marc Otero-Mateo, Giancarlo Castellano, Rafael Moreno, David Medel, Ramon Alemany, Eneko Villanueva & Cristina Fillat. (2021) Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses. NAR Cancer 3:2.
Crossref
Crossref
Dayananda Kasala, JinWoo Hong & Chae-Ok Yun. (2021) Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective. Journal of Controlled Release 332, pages 285-300.
Crossref
Crossref
Shalini Sundramurthi Chelliah, Ervin Ashley Lourdes Paul, Muhamad Noor Alfarizal Kamarudin & Ishwar Parhar. (2021) Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas. Molecules 26:4, pages 1169.
Crossref
Crossref
Chibawanye I. Ene, Juan Fueyo & Frederick F. Lang. (2021) Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations. Neurosurgical Focus 50:2, pages E6.
Crossref
Crossref
Visish M. SrinivasanFrederick F. Lang & Peter Kan. (2021) Intraarterial delivery of virotherapy for glioblastoma. Neurosurgical Focus 50:2, pages E7.
Crossref
Crossref
Juri Kiyokawa, Yoichiro Kawamura, Shanawaz M. Ghouse, Simge Acar, Erinç Barçın, Jordi Martínez-Quintanilla, Robert L. Martuza, Ramon Alemany, Samuel D. Rabkin, Khalid Shah & Hiroaki Wakimoto. (2021) Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma. Clinical Cancer Research 27:3, pages 889-902.
Crossref
Crossref
Junpei Kano, Naoya Koizumi, Airi Terada, Ayana Matsuoka, Takamasa Hirai, Tetsuya Nomura, Hiroyuki Mizuguchi & Naoki Utoguchi. (2021) Fiber-Knob Region of Adenovirus Type 5 Vector Promotes Migration of A549 Cells. BPB Reports 4:1, pages 17-21.
Crossref
Crossref
Karina Kawka, A. Noelle Wilton, Pedram Madadkar, Maria Fe C. Medina, Brian D. Lichty, Raja Ghosh & David R. Latulippe. (2021) Integrated development of enzymatic DNA digestion and membrane chromatography processes for the purification of therapeutic adenoviruses. Separation and Purification Technology 254, pages 117503.
Crossref
Crossref
June Kyu Hwang, JinWoo Hong & Chae-Ok Yun. (2020) Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials. International Journal of Molecular Sciences 21:22, pages 8627.
Crossref
Crossref
Tabitha G. Cunliffe, Emily A. Bates & Alan L. Parker. (2020) Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies. Cancers 12:11, pages 3327.
Crossref
Crossref
Sergio Rius-Rocabert, Noemí García-Romero, Antonia García, Angel Ayuso-Sacido & Estanislao Nistal-Villan. (2020) Oncolytic Virotherapy in Glioma Tumors. International Journal of Molecular Sciences 21:20, pages 7604.
Crossref
Crossref
Yvonne Cashinn Chia, Clarice Evey Anjum, Hui Rong Yee, Yenny Kenisi, Mike K. S. Chan, Michelle B. F. Wong & Shing Yi Pan. (2020) Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?. Stem Cells International 2020, pages 1-8.
Crossref
Crossref
Silvia Valtorta, Daniela Salvatore, Paolo Rainone, Sara Belloli, Gloria Bertoli & Rosa Maria Moresco. (2020) Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance. International Journal of Molecular Sciences 21:16, pages 5631.
Crossref
Crossref
Agata Hadryś, Aleksander Sochanik, Grant McFadden & Joanna Jazowiecka-Rakus. (2020) Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses. European Journal of Pharmacology 874, pages 172991.
Crossref
Crossref
Shiqi Kong, Yanwei Fang, Bingqian Wang, Yingxiao Cao, Runzhi He & Zongmao Zhao. (2020) miR‐152‐5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7. Journal of Cellular and Molecular Medicine 24:8, pages 4569-4579.
Crossref
Crossref